
AstraZeneca Unveils $50 Billion U.S. Investment to Boost Drug Manufacturing and Jobs
AstraZeneca is set to revolutionize U.S. healthcare with a staggering $50 billion investment aimed at boosting drug manufacturing and creating thousands of jobs by 2030. This bold move promises to reshape the landscape of metabolic and weight management treatments, underscoring the company’s commitment to innovation and economic growth. Discover how this investment could transform the industry and impact patients nationwide.







